Guideline Quick View: Venous Thromboembolism

Size: px
Start display at page:

Download "Guideline Quick View: Venous Thromboembolism"

Transcription

1 Guideline Quick View: Venous Thromboembolism The AORN Guideline Quick View is a key component of Guideline Essentials, a suite of online implementation tools designed to help the perioperative team translate AORN s evidence- based guidelines into practice. Each Guideline Quick View highlights important elements of the full guideline and includes images, implementation steps, and the rationale for why these steps are important to promote safety and optimal outcomes for patients undergoing operative and other invasive procedures. Access to the full set of Guideline Essentials is included with AORN membership. To access them online, visit Facilities can provide team access to these resources by purchasing a subscription to Guidelines Plus and other products on the AORN Facility Reference Center platform. For more information, visit PREVENTION PROTOCOL Establish and implement a protocol for the prevention of venous thromboembolism (VTE) that: - is evidence-based - is easy to use in clinical practice - includes a standardized assessment of VTE and bleeding risk - provides clinical decision support for evidence-based prophylaxis based on level of risk for VTE and bleeding - includes a start time (eg, upon admission, before surgery, after surgery) for all types of prophylaxis based on the clinical condition of the patient - uses alerts to notify clinicians of a potential lapse in prophylaxis according to the VTE protocol An organization-wide protocol that is developed using evidence-based professional guidelines and that includes clinical decision support for prophylactic choices prompts health care providers to give consistent and effective care for the prevention of VTE. VTE prophylaxis may be pharmaceutical or mechanical. Mechanical prophylaxis includes the use of intermittent pneumatic compression devices, use of graduated compression stockings, early ambulation, and foot and ankle exercises. PREOPERATIVE PATIENT ASSESSMENT Conduct a preoperative patient assessment to determine VTE risk factors, - age greater than 40 years - cancer or cancer treatment - obesity - previous history of VTE or stroke - prolonged bed rest or immobilization longer than 3 days - varicose veins - presence of a central venous catheter - trauma - spinal cord injury - inherited or acquired thrombophilia AORN, Inc, 2018 AORN Journal 281

2 - estrogen therapy - critical care admission - dehydration - comorbidities (eg, heart disease, metabolic/endocrine disease, respiratory disease, acute infectious disease, inflammatory conditions) - pregnancy and the postpartum period - smoking - steroid therapy - ASA physical status classification of 3 or higher - recent surgery - preoperative hospitalization - blood transfusion - known non-o blood type - obstructive sleep apnea - asplenia The causative factors of venous thrombus formation, commonly referred to as Virchow s Triad, include venous stasis, vessel wall injury, and hypercoagulability. The preoperative assessment provides information necessary to determine the individual patient s risk for VTE and identify prophylactic measures recommended by the health care organization s VTE protocol. - any open procedure - emergency procedure - concurrent procedures - transplant surgery - cesarean delivery - major foot and ankle surgery - major hand, wrist, or elbow surgery - procedures involving hardware placement - major plastic surgery All perioperative patients including children may be at risk for VTE because of immobility, vessel injury, and compression of tissue caused by retraction and patient positioning requirements. PROCEDURE- RELATED RISK FACTORS Conduct a preoperative patient assessment for procedure-related risk factors, - duration of surgery (ie, longer than 90 minutes, or longer than 60 minutes for procedures involving a lower limb or the pelvis) - intraoperative patient position (eg, excessive hip flexion, hyperextension of the knee, reverse Trendelenburg) - use of a pneumatic tourniquet - major orthopedic surgery - bariatric surgery - cardiothoracic surgery - vascular surgery - urologic or general surgery involving the abdomen or pelvis - neurosurgery - spine surgery - immobilizing cast of a lower extremity INTERMITTENT PNEUMATIC COMPRESSION DEVICES use of intermittent pneumatic compression devices, - any leg condition that the device may exacerbate (eg, dermatitis, recent skin graft) - known allergy or sensitivity to the sleeve or tubing material - cardiac failure or pulmonary edema from congestive heart failure - any factor that prevents correct fitting of the sleeves (eg, exceeding size limit, severe leg edema, deformity) - preexisting deep vein thrombosis - severe arteriosclerosis or other ischemic vascular disease Notify the prescriber and anesthesia professional of any contraindications to use of the device. 282 AORN Journal

3 Apply the device according to the manufacturer s instructions for use. When applying the sleeves, place the tubing on the external surface of the sleeve facing away from the patient s skin and away from locations that may create a pressure injury. Leave the intermittent pneumatic compression device in place for a minimum of 18 hours daily during the intraoperative and immediate postoperative period. of pneumatic compression devices, - skin injury - hypothermia - numbness, tingling, discomfort, or pain - ischemia Intermittent pneumatic compression reduces VTE risk while also reducing the risk for major bleeding in surgical patients. The addition of intermittent pneumatic compression to pharmacologic prophylaxis reduces the risk for VTE compared to either modality alone. GRADUATED COMPRESSION STOCKINGS use of graduated compression stockings, - any skin conditions that stockings may exacerbate (eg, dermatitis, recent skin graft, leg ulcer) - any vascular conditions that stockings may exacerbate (eg, peripheral vascular disease, peripheral arterial bypass grafting, severe arteriosclerosis) - severe peripheral neuropathy or other sensory impairment - gangrene - known allergy or sensitivity to stocking material - cardiac failure or pulmonary edema from congestive heart failure - any factor that prevents correct fitting of stockings (eg, exceeding the size limit, severe leg edema, deformity) Notify the prescriber and anesthesia professional of any contraindications to use of the stockings. Fit graduated compression stockings to the individual patient. Measure the patient s legs separately and according to the manufacturer s instructions. Apply graduated compression stockings before the administration of regional or general anesthesia. Verify that: - stockings are not rolled up the foot or down the leg - stockings are smooth when fitted - toe holes lie underneath the toes - heel patches are in the correct position - thigh gussets are positioned on the inner thigh Do not use elastic bandages as a replacement for graduated compression stockings. For patients who develop postoperative leg edema, remove the stockings, remeasure the legs, and refit the stockings. of graduaated compression stockings, - skin injury - numbness, tingling, discomfort, or pain - proximal indentation from knee-length graduated compression stockings - ischemia Graduated compression stockings are often used in combination with intermittent pneumatic compression devices and pharmaceutical prophylaxis. Patients may be harmed by wearing graduated compression stockings when the stockings are incorrectly worn or sized. AORN Journal 283

4 PHARMACOLOGIC VTE PROPHYLAXIS use of pharmacologic VTE prophylaxis, - active bleeding - previous major bleeding - known, untreated bleeding disorder - severe renal or hepatic failure - thrombocytopenia - acute stroke - uncontrolled systemic hypertension - lumbar puncture or epidural or spinal anesthesia within the previous 4 hours or subsequent 12 hours - concomitant use of anticoagulants, antiplatelet therapy, or thrombolytic drugs - procedures in which bleeding complications may have especially severe consequences (eg, craniotomy, spinal surgery, spinal trauma, reconstructive procedures involving a free flap) - bacterial endocarditis - allergy to medication - pregnancy - ophthalmic surgery - prosthetic heart valve Notify the prescriber of any identified contraindica tions. of pharmacologic VTE prophylaxis, - bleeding - hematoma - thrombocytopenia - osteoporosis and osteopenia - skin necrosis - calciphylaxis - atheroembolism - injection site irritation, pain, bruising, bleeding, or itching - Notify the prescriber and anesthesia professional of any identified adverse effects. Pharmacologic prophylaxis consists of administering anticoagulant mediations that inhibit blood clotting. The pharmacologic regimen may include medications such as low molecular weight heparin, low-dose unfractionated heparin, warfarin, factor Xa inhibitors, dabigatran, vitamin K antagonists, or aspirin. POSTOPERATIVE MOBILITY Help the patient to ambulate as soon as possible after surgery. Collaborate with the perioperative team to minimize barriers to postoperative ambulation, - inadequate pain control - pain management techniques that reduce patient mobility (eg, regional anesthesia) - an indwelling catheter - IV infusion - lack of patient motivation (sedation) Implement measures to prevent falls during postoperative ambulation. Instruct the patient to perform postoperative foot and ankle exercises. Ambulation decreases venous stasis by creating natural compression of the venous system through muscle contraction and compression. Foot and ankle exercises decrease venous stasis by creating natural compression of the venous system through muscle contraction. 284 AORN Journal

5 PREOPERATIVE AND POSTOPERATIVE INSTRUCTIONS Provide the patient and his or her designated caregiver(s) with written and verbal instructions on prevention of VTE, including information about: - the common signs and symptoms of deep vein thrombosis or pulmonary embolism (eg, leg pain, swelling, unexplained shortness of breath, wheezing, chest pain, palpitations, anxiety, sweating, coughing up blood) - the importance of mobilization, including ambulation and foot and ankle exercises - maintaining adequate hydration - preventive measures to use when traveling long distances after surgery (eg, frequent ambulation; calf muscle exercise; wearing fitted, knee-length graduated compression stockings) - elevating the legs - avoiding clothing that constricts the lower extremities - avoiding sitting with knees bent or legs crossed for long periods of time - avoiding sitting or standing for long periods of time Provide the patient receiving mechanical prophylaxis with preoperative and postoperative instructions, - the benefits of mechanical prophylaxis - the importance of compliance - instruction on removal and reapplication of graduated compression stockings and intermittent compression devices - the importance of postoperative ambulation - the potential for skin injury (eg, marking, blistering), ischemia, numbness, tingling, discomfort, or pain - who to contact if the patient has problems using the prescribed prophylaxis Provide the patient receiving pharmacologic VTE prophylaxis with preoperative and postoperative instructions, - the importance of following through with medicationrelated laboratory tests - the importance of continuing medication post discharge as prescribed - who to contact if there are any problems self- administering the prescribed pharmacologic prophylaxis - the importance of not stopping medication or not starting new medication, including over-the-counter medications (eg, aspirin, ibuprofen), without consulting the physician - potential adverse effects and when to seek medical attention - interactions with herbal and other over-the-counter preparations (eg, ginger, ginkgo biloba) - reporting signs of bleeding - carrying or wearing medication identification to let health care providers know that the patient is on anticoagulation therapy Education related to VTE prevention may reduce the patient s risk for developing VTE by increasing the patient s awareness and, potentially, compliance with prophylaxis. DOCUMENTATION Document activities for prevention of VTE, - pharmacologic prophylaxis administration (eg, medication, dose, time, route) - contraindications to mechanical or pharmacologic prophylaxis and actions taken - adverse effects from mechanical or pharmacologic prophylaxis and actions taken - patient education provided - the reason for any variance from the VTE protocol - the type and size of the intermittent pneumatic compression sleeve and graduated compression stockings applied - results of a fall risk assessment and measures taken to prevent patient falls during postoperative ambulation - application and removal times for all mechanical prophylactic measures - intermittent pneumatic compression device identification (eg, serial or biomedical number) and settings - results of a patient skin assessment for mechanical prophylactic measures Documentation in the patient s medical record provides a description of the perioperative care administered, status of patient outcomes upon transfer, and information to support continuity of care. Documentation provides data for identifying trends and demonstrating compliance with regulatory requirements and accreditation standards. AORN Journal 285

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge What is a venous thromboembolism (VTE)? This is a medical term that describes a blood clot that develops in a deep vein

More information

Slide 1. Slide 2. Slide 3. Outline of This Presentation

Slide 1. Slide 2. Slide 3. Outline of This Presentation Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous

More information

Venous thromboembolism - reducing the risk

Venous thromboembolism - reducing the risk Venous thromboembolism - reducing the risk Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital NICE guideline Draft for consultation,

More information

Venous thromboembolism: reducing the risk

Venous thromboembolism: reducing the risk Issue date: January 2010 Venous thromboembolism: reducing the risk Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital This guideline

More information

Anticoagulation for prevention of venous thromboembolism

Anticoagulation for prevention of venous thromboembolism Anticoagulation for prevention of venous thromboembolism Original article by: Michael Tam Note: updated in June 2009 with the eighth edition (from the seventh) evidence-based clinical practice guidelines

More information

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section. TITLE VENOUS THROMBOEMBOLISM PROPHYLAXIS SCOPE Provincial Acute and Sub-Acute Care Facilities APPROVAL AUTHORITY Alberta Health Services Executive Committee SPONSOR Vice President, Quality and Chief Medical

More information

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY N.E. Pearce INTRODUCTION Preventable death Cause of morbidity and mortality Risk factors Pulmonary embolism

More information

Venous Thromboembolism. Prevention

Venous Thromboembolism. Prevention Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and

More information

Venous Thromboembolism Prophylaxis

Venous Thromboembolism Prophylaxis Approved by: Venous Thromboembolism Prophylaxis Vice President and Chief Medical Officer; and Vice President and Chief Operating Officer Corporate Policy & Procedures Manual Number: Date Approved January

More information

How to prevent blood clots whilst in hospital and after your return home

How to prevent blood clots whilst in hospital and after your return home How to prevent blood clots whilst in hospital and after your return home Patient information WHAT What IS is DEEP deep VEIN vein THROMBOSIS? thrombosis? Deep Vein Thrombosis DVT is a blood clot within

More information

NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1

NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1 The College of Emergency Medicine Patron: HRH The Princess Royal Churchill House Tel +44 (0)207 404 1999 35 Red Lion Square Fax +44 (0)207 067 1267 London WC1R 4SG www.collemergencymed.ac.uk CLINICAL EFFECTIVENESS

More information

VTE Prophylaxis. NEW NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients

VTE Prophylaxis. NEW NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients NEW NICE guidance NICE guidance (MTG19) supports the use of the geko device for people who have a high risk of VTE and for whom pharmacological or other mechanical methods of VTE prevention are impractical

More information

VTE Prophylaxis. NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients

VTE Prophylaxis. NICE guidance. Providing venous thromboembolism (VTE) prophylaxis to all at risk hospital patients NICE guidance NICE guidance (MTG19) supports the use of the geko device for people who have a high risk of VTE and for whom pharmacological or other mechanical methods of VTE prevention are impractical

More information

Deep Vein Thrombosis

Deep Vein Thrombosis Deep Vein Thrombosis from NHS (UK) guidelines Introduction Deep vein thrombosis (DVT) is a blood clot in one of the deep veins in the body. Blood clots that develop in a vein are also known as venous thrombosis.

More information

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk? Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP

More information

DVT - initial management NSCCG

DVT - initial management NSCCG Background information Information resources for patients and carers Updates to this care map Synonyms Below knee DVT and bleeding risks Patient with confirmed DVT Scan confirms superficial thrombophlebitis

More information

Venothromboembolism prophylaxis: Trauma and Orthopaedics Clinical guideline, V2

Venothromboembolism prophylaxis: Trauma and Orthopaedics Clinical guideline, V2 Clinical Guideline Venothromboembolism prophylaxis: Trauma and Orthopaedics 11/11/11 TEMPORARY GUIDANCE There is no prophylactic tinzaparin available in the Trust currently. Please substitute enoxaparin

More information

Misunderstandings of Venous thromboembolism prophylaxis

Misunderstandings of Venous thromboembolism prophylaxis Misunderstandings of Venous thromboembolism prophylaxis Veerendra Chadachan Senior Consultant Dept of General Medicine (Vascular Medicine and Hypertension) Tan Tock Seng Hospital, Singapore Case scenario

More information

These are guidelines only and can be deviated from if it is thought to be in the patient s best interest.

These are guidelines only and can be deviated from if it is thought to be in the patient s best interest. Clinical Guideline Venothromboembolism prophylaxis: Trauma and Orthopaedics Venous thromboembolism (VTE) is a recognised complication associated with inactivity and surgical procedures. Therefore, all

More information

Deep venous thrombosis and pulmonary embolism in joint replacement surgery

Deep venous thrombosis and pulmonary embolism in joint replacement surgery Deep venous thrombosis and pulmonary embolism in joint replacement surgery Even though joint replacement surgery is an effective procedure and in expert hands yields a low complication rate, deep venous

More information

Mabel Labrada, MD Miami VA Medical Center

Mabel Labrada, MD Miami VA Medical Center Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and

More information

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help

Understanding your risk of blood clots from hospital to home and how Bevyxxa may help Understanding your risk of blood clots from hospital to home and how Bevyxxa may help People who take Bevyxxa and have medicine injected into their spinal and epidural area, or have a spinal puncture,

More information

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2017 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community Venous Thrombosis Venous Thrombosis It occurs mainly in the deep veins of the leg (deep vein thrombosis, DVT), from which parts of the clot frequently embolize to the lungs (pulmonary embolism, PE). Fewer

More information

1. SCOPE of GUIDELINE:

1. SCOPE of GUIDELINE: Page 1 of 35 CLINICAL PRACTICE GUIDELINE: Venous Thromboembolism (VTE) Prevention Guideline: Thromboprophylaxis AUTHORIZATION: VP, Medicine Date Approved: May 17, 2012 Date Revised: Vancouver Coastal Health

More information

New v1.0 Date: December 2015 Patricia Wain - Associate Director Physical Care. Kenny Laing - Deputy Director of Nursing

New v1.0 Date: December 2015 Patricia Wain - Associate Director Physical Care. Kenny Laing - Deputy Director of Nursing Clinical Venous Thromboembolism: Standing Operating Procedure Document Control Summary Status: Version: Author/Title: Owner/Title: New v1.0 Date: December 2015 Patricia Wain - Associate Director Physical

More information

Deep Vein Thrombosis

Deep Vein Thrombosis Deep Vein Thrombosis Introduction Deep vein thrombosis (DVT) is a blood clot in a vein. This condition can affect men and women of any age and race. DVT is a potentially serious condition. If not treated,

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

Preventing Blood Clots in Adult Patients

Preventing Blood Clots in Adult Patients Manchester Royal Eye Hospital Surgical Services Information for Patients Preventing Blood Clots in Adult Patients This leaflet will give you information on how to reduce the risk of developing blood clots

More information

What You Should Know

What You Should Know 1 New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know The American Society

More information

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4 TELEMETRY BED TRANSFER 1 of 4 9 Actual 9 Estimated Patient ID Area Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Transfer to: 10 South Attending Physician: Diagnosis:

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

Patient Information. Preventing and treating blood clots

Patient Information. Preventing and treating blood clots Patient Information Preventing and treating blood clots 1_Clexane_Patient_Booklet_AW05.indd 1 8/04/2016 11:26 a The information provided in this document is for patients prescribed CLEXANE, and should

More information

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593 Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) National Quality Strategy Domain: Patient Safety 2015 PQRS OPTIONS FOR INDIVIDUAL MEASURES:

More information

NICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89

NICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89 Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NICE guideline Published: 21 March 2018 nice.org.uk/guidance/ng89 NICE 2018. All rights

More information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur

More information

Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis. By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan

Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis. By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan Objectives Describe the prevalence of PE and DVT as it relates

More information

GENERAL SURGICAL ADULT POST-OPERATIVE ORDERS 1 of 4

GENERAL SURGICAL ADULT POST-OPERATIVE ORDERS 1 of 4 down ADULT POST-OPERATIVE 1 of 4 9 Actual 9 Estimated Patient ID Area Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART Admit to: Post Anesthesia Care Unit (PACU),

More information

ADULT CARDIAC SURGERY TELEMETRY BED TRANSFER ORDERS 1 of 4

ADULT CARDIAC SURGERY TELEMETRY BED TRANSFER ORDERS 1 of 4 ADULT CARDIAC SURGERY TELEMETRY BED TRANSFER 1 of 4 9 Actual 9 Estimated Attending Surgeon: Medical Record Number Weight kg 9 Actual 9 Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART

More information

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban)

To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) To prevent blood clots after hip or knee replacement surgery This booklet contains information for those who have been prescribed ELIQUIS (apixaban) after hip or knee replacement surgery Always read the

More information

Venous Thrombo-Embolism (VTE)

Venous Thrombo-Embolism (VTE) Venous Thrombo-Embolism (VTE) Information for service users and carers RDaSH leading the way with care Older People s Mental Health Services Reducing risk of unwanted blood clots whilst in hospital About

More information

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date: Clinical Policy: (Fragmin) Reference Number: ERX.SPA.207 Effective Date: 01.11.17 Last Review Date: 02.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

THROMBOSIS RISK FACTOR ASSESSMENT

THROMBOSIS RISK FACTOR ASSESSMENT Name: Procedure: Doctor: Date: THROMBOSIS RISK FACTOR ASSESSMENT CHOOSE ALL THAT APPLY EACH RISK FACTOR REPRESENTS 1 POINT Age 41 60 years Minor Surgery Planned History of Prior Major Surgery (< 1 month)

More information

Preventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy

Preventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy Preventing blood clots while you are in hospital and after you leave Information for patients Pharmacy Why does blood clot? When we cut ourselves, we bleed. To stop us from bleeding too much, chemicals

More information

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY OBJECTIVE: To outline a practical approach for the prevention of venous thromboembolism (VTE) in patients undergoing non-orthopedic surgery. BACKGROUND: VTE is

More information

VTE Prevention Guidelines (Venous Thromboembolism) (Venous Thromboembolism)

VTE Prevention Guidelines (Venous Thromboembolism) (Venous Thromboembolism) VTE Prevention Guidelines (Venous Thromboembolism) (Venous Thromboembolism) When using this document please ensure that the version you are using is the most up to date either by checking on the Trust

More information

Perioperative VTE Prophylaxis

Perioperative VTE Prophylaxis Perioperative VTE Prophylaxis Gregory J. Misky, M.D. Assistant Professor of Medicine University Of Colorado Denver You recommend the following 72 y.o. man admitted for an elective R hip repair. Patient

More information

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital

More information

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None Disclosures DVT: Diagnosis and Treatment None Susanna Shin, MD, FACS Assistant Professor University of Washington Acute Venous Thromboembolism (VTE) Deep Venous Thrombosis (DVT) Pulmonary Embolism (PE)

More information

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement Marilyn Szekendi, PhD, RN ANA 7 th Annual Nursing Quality Conference, February 2013 Research Team Banafsheh Sadeghi,

More information

Questionnaire for Lipedema Patients

Questionnaire for Lipedema Patients Questionnaire for Lipedema Patients Name Date of diagnosis Date Name of physician making diagnosis Do you also have lymphedema? What areas of the body are affected? Outside of thighs Inner thighs Knees

More information

General. Recommendations. Guideline Title. Bibliographic Source(s) Guideline Status. Major Recommendations

General. Recommendations. Guideline Title. Bibliographic Source(s) Guideline Status. Major Recommendations General Guideline Title Prevention of deep vein thrombosis and pulmonary embolism. Bibliographic Source(s) American College of Obstetricians and Gynecologists (ACOG). Prevention of deep vein thrombosis

More information

Deep Vein Thrombosis and Pulmonary Embolism: Risks, Prevention & Treatment

Deep Vein Thrombosis and Pulmonary Embolism: Risks, Prevention & Treatment Deep Vein Thrombosis and Pulmonary Embolism: Risks, Prevention & Treatment Other formats If you need this information in another format such as audio tape or computer disk, Braille, large print, high contrast,

More information

Preventing Venous Thromboembolism (VTE)

Preventing Venous Thromboembolism (VTE) INTERNET INFORMATION SOURCES North American Thrombosis Forum www.natfonline.org Clot Care www.clotcare.com MANITOUWADGE GENERAL HOSPITAL National Alliance for Thrombosis/Thrombophilia www.stoptheclot.org

More information

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients What is a deep vein thrombosis (DVT)? A DVT is a blood clot that forms within a vein deep in the leg but can

More information

Prevention of Venous Thromboembolism

Prevention of Venous Thromboembolism Prevention of Venous Thromboembolism Reference No: P_CS_05 Version 2.4 Ratified by: LCHS Trust Board Date ratified: 27 th January 2015 Name of originator / author: Medical Director Name of responsible

More information

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE in Surgical Patients: Recognizing the Patients at Risk Pathogenesis of thrombosis: Virchow s triad and VTE Risk Hypercoagulability

More information

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date:

Clinical Policy: Dalteparin (Fragmin) Reference Number: ERX.SPA.207 Effective Date: Clinical Policy: (Fragmin) Reference Number: ERX.SPA.207 Effective Date: 01.11.17 Last Review Date: 11.17 Revision Log See Important Reminder at the end of this policy for important regulatory and legal

More information

Getting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis

Getting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis Reducing Harm Improving Healthcare Protecting Canadians VENOUS THROMBOEMBOLISM PREVENTION Getting Started Kit Section 2: Evidence-Based Appropriate VTE Prophylaxis January 2017 www.patientsafetyinstitute.ca

More information

Cancer and the Risk of Blood Clots

Cancer and the Risk of Blood Clots Patient & Family Guide 2018 Cancer and the Risk of Blood Clots www.nscancercare.ca Table of Contents Terms Used in this Booklet 1 What are Blood Clots? 2 When are Cancer Patients at the Highest Risk for

More information

GUIDELINE FOR THROMBOPROPHYLAXIS IN ADULT (18 YEARS AND OLDER) IN GENERAL MEDICAL PATIENTS AND INPATIENTS UNDERGOING SURGERY

GUIDELINE FOR THROMBOPROPHYLAXIS IN ADULT (18 YEARS AND OLDER) IN GENERAL MEDICAL PATIENTS AND INPATIENTS UNDERGOING SURGERY GUIDELINE FOR THROMBOPROPHYLAXIS IN ADULT (18 YEARS AND OLDER) IN GENERAL MEDICAL PATIENTS AND INPATIENTS UNDERGOING SURGERY SEE SEPARATE GUIDELINES FOR THROMBOPROPHYLAXIS IN OBSTETRICS This guidance does

More information

Venous Thromboembolism (VTE) Prevention

Venous Thromboembolism (VTE) Prevention Venous Thromboembolism (VTE) Prevention 7 VTE Risk Assessment: General Patient Population Assess VTE risk at admission, post-op, and transfer See page 2 for VTE risk assessment among Obstetrical (OB) patients

More information

OBSTETRIC ADMISSION ORDERS 1 of 4

OBSTETRIC ADMISSION ORDERS 1 of 4 OBSTETRIC ADMISSION 1 of 4 Actual Estimated Weight kg Actual Estimated Height cm ALLERGIES: REFER TO ALLERGY PROFILE/ POWERCHART ADMIT TO: Labor and Delivery ( ) Check, circle and/or fill in all orders

More information

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins

Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Tameside Hospital NHS Foundation Trust and NHS Tameside and Glossop Shared Care Protocol for the Prescription and Supply of Low Molecular Weight Heparins Version 5.2 Version: 5.2 Authorised by: Joint Medicines

More information

Understand. your risk of. blood clot

Understand. your risk of. blood clot Going into hospital? Understand how to reduce your risk of developing a blood clot Printing of this leaflet has been supported by a donation from Bayer HealthCare. Bayer HealthCare has had no editorial

More information

*Corresponding Author:

*Corresponding Author: Audit of venous thromboembolism prophylaxis administered to general surgical patients undergoing elective and emergency operations at National Hospital, Sri Lanka *Migara Seneviratne 1, Asanka Hemachandra

More information

Our Commitment to Quality and Patient Safety Core Measures

Our Commitment to Quality and Patient Safety Core Measures Calvert Memorial Hospital is committed to our community, with a focus on patient-centered care. High quality and safe patient care is not our goal, it is our priority. That means delivering the best possible

More information

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the

More information

Venous Thromboembolic Events (VTEs)

Venous Thromboembolic Events (VTEs) Venous Thromboembolic Events (VTEs) This Infosheet explains what a VTE is, what the causes and risk factors for VTEs are, the symptoms of a VTE, how they can be treated and some tips for self-management.

More information

NOTE: Deep Vein Thrombosis (DVT) Risk Factors

NOTE: Deep Vein Thrombosis (DVT) Risk Factors Deep Vein Thrombosis (DVT) Deep Vein Thrombosis (DVT) is the formation of a blood clot, known as a thrombus, in the deep leg vein. It is a very serious condition that can cause permanent damage to the

More information

10/8/2012. Disclosures. Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines. Goals and Objectives. Outline

10/8/2012. Disclosures. Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines. Goals and Objectives. Outline Disclosures Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines No relevant conflicts of interest related to the topic presented. Cyndy Brocklebank, PharmD, CDE Chronic Disease Management

More information

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital VTE is common and dangerous 5 VTE is Common VTE Incidence: 1.5 / 1000 per year

More information

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP PE and DVT Dr Anzo William Adiga WatsApp or Call +256777363201 Medical Officer/RHEMA MEDICAL GROUP OBJECTIVES DEFINE DVT AND P.E PATHOPHYSIOLOGY OF DVT CLINICAL PRESENTATION OF DVT/PE INVESTIGATE DVT MANAGEMENT

More information

Venous Thromboembolism (VTE) A guide for patients with cancer

Venous Thromboembolism (VTE) A guide for patients with cancer Cancer Patient InformationPtient Education Inform Venous Thromboembolism (VTE) A guide for patients with cancer Table of Contents Venous Thromboembolism (VTE)... 3 Deep Vein Thrombosis (DVT) and Pulmonary

More information

DEEP VEIN THROMBOSIS (DVT): TREATMENT

DEEP VEIN THROMBOSIS (DVT): TREATMENT DEEP VEIN THROMBOSIS (DVT): TREATMENT OBJECTIVE: To provide an evidence-based approach to treatment of patients presenting with deep vein thrombosis (DVT). BACKGROUND: An estimated 45,000 patients in Canada

More information

Prevention of Venous Thromboembolism

Prevention of Venous Thromboembolism Prevention of Venous Thromboembolism Surgical Care Improvement Project Dale W. Bratzler, DO, MPH President and CEO Dale W. Bratzler, DO, MPH Oklahoma Foundation for Medical Quality QIOSC Medical Director

More information

Treatment with Rivaroxaban Xarelto

Treatment with Rivaroxaban Xarelto Treatment with Rivaroxaban Xarelto Anticoagulation Clinic This handout explains the medicine rivaroxaban, a drug that helps prevent blood clots. What is rivaroxaban? Rivaroxaban (brand name Xarelto) is

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Postsurgical Home Use of Limb Compression Devices for Venous File Name: Origination: Last CAP Review: Next CAP Review: Last Review: postsurgical_home_use_of_limb_ compression_devices_for_vte_prophylaxis

More information

Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship

Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship CLINICAL PROBLEMS IN VASCULAR SURGERY 1. ABDOMINAL AORTIC ANEURYSM A 70 year old man presents in the emergency department with

More information

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets

MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets MEDICATION GUIDE ELIQUIS (ELL eh kwiss) (apixaban) tablets What is the most important information I should know about ELIQUIS? For people taking ELIQUIS for atrial fibrillation: People with atrial fibrillation

More information

Anticoagulant treatment for DVT

Anticoagulant treatment for DVT Anticoagulant treatment for DVT A guide to your diagnosis and the choice of treatment For more information, please contact: Please see contact details on page 23 of this booklet Caring with pride 2 Caring

More information

VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017

VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017 VENOUS THROMBOEMBOLISM (VTE) PREVENTION MEDICAL PROVIDER EDUCATION JUNE 2017 VTE IS THE 2 ND MOST COMMON HOSPITAL ACQUIRED CONDITION RISK FACTORS DECREASED ACTIVITY = VTE RISK (NURSES MEASURE WITH BRADEN

More information

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 7 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including

More information

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS PROPHYLAXIS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent

More information

How varicose veins occur

How varicose veins occur Varicose veins are a very common problem, generally appearing as twisting, bulging rope-like cords on the legs, anywhere from groin to ankle. Spider veins are smaller, flatter, red or purple veins closer

More information

Confirmed blood clot

Confirmed blood clot n The Leeds Teaching Hospitals NHS Trust Confirmed blood clot (Deep vein thrombosis and pulmonary embolism) Information for patients Please read this leaflet carefully. It will give you information about

More information

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 8 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Clinical Practice Guideline for Patients Requiring Total Hip Replacement

Clinical Practice Guideline for Patients Requiring Total Hip Replacement Clinical Practice Guideline for Patients Requiring Total Hip Replacement Inclusions Patients undergoing elective total hip replacement Exclusions Patients with active local or systemic infection or medical

More information

Sores That Will Not Heal

Sores That Will Not Heal Sores That Will Not Heal Introduction Some sores have trouble healing on their own. Sores that will not heal are a common problem. Open sores that will not heal are also known as wounds or skin ulcers.

More information

Deep Vein Thrombosis and Pulmonary Embolism

Deep Vein Thrombosis and Pulmonary Embolism Page 1 of 12 PATIENT EDUCATION Deep Vein Thrombosis and Pulmonary Embolism Take Steps to Prevent DVTs and PEs Deep vein thrombosis and pulmonary embolism are serious conditions that can affect people of

More information

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients?

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients? July 2015 Rapid Review Evidence Summary McGill University Health Centre: Division of Nursing Research and MUHC Libraries What evidence exists that describes the efficacy of mechanical prophylaxis for venous

More information

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies

MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND COMPRESSION GARMENTS. POLICY NUMBER: CATEGORY: Equipment/ Supplies MEDICAL POLICY SUBJECT: SURGICAL STOCKINGS AND PAGE: 1 OF: 7 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical policy

More information

Patient Information. Venous Insufficiency and Varicose Veins

Patient Information. Venous Insufficiency and Varicose Veins Patient Information Venous Insufficiency and Varicose Veins What is a Varicose Vein? Gitter Vein Institute-revised 3/8/2016 2 Frequently Asked Questions What is the difference between varicose and spider

More information

Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital

Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital Management of the complications of myeloma and side-effects of treatment Christine Morris Clinical Nurse Specialist in Myeloma Royal Derby Hospital Common problems in myeloma Myeloma-related complications/symptoms

More information

Introduction 3. What is Peripheral Vascular Disease? 5. What Are Some of the Symptoms of Peripheral Vascular Disease? 6

Introduction 3. What is Peripheral Vascular Disease? 5. What Are Some of the Symptoms of Peripheral Vascular Disease? 6 Patient Information Table of Contents Introduction 3 What is Peripheral Vascular Disease? 5 What Are Some of the Symptoms of Peripheral Vascular Disease? 6 What Causes Peripheral Vascular Disease? 7 How

More information

CHAPTER 2 VENOUS THROMBOEMBOLISM

CHAPTER 2 VENOUS THROMBOEMBOLISM CHAPTER 2 VENOUS THROMBOEMBOLISM Objectives Venous Thromboembolism (VTE) Prevalence Patho-physiology Risk Factors Diagnosis Pulmonary Embolism (PE) Management of DVT/PE Prevention VTE Patho-physiology

More information

How is 1st MTP joint fusion carried out? Patient Information: Big Toe Fusion Metatarsophalangeal (MTP)

How is 1st MTP joint fusion carried out? Patient Information: Big Toe Fusion Metatarsophalangeal (MTP) Patient Information: Big Toe Fusion Metatarsophalangeal (MTP) How is 1st MTP joint fusion carried out? You will be asked to wash your feet thoroughly on the day of operation and keep them clean, as this

More information

Tarkten A Pharr, MD, FACS 04/26/2018. VTE Prevention Strategies: Is a One Size Fits all Approach Correct?

Tarkten A Pharr, MD, FACS 04/26/2018. VTE Prevention Strategies: Is a One Size Fits all Approach Correct? Tarkten A Pharr, MD, FACS 04/26/2018 VTE Prevention Strategies: Is a One Size Fits all Approach No disclosures... Why do we care? Where is this is the realm of public health concerns? Incidence/Prevalence

More information

Treatment with Apixaban Eliquis

Treatment with Apixaban Eliquis Treatment with Apixaban Eliquis Anticoagulation Clinic 416-530-6000 ext 3477 This handout explains the medicine rivaroxaban, a drug that helps prevent blood clots. What is apixaban? Apixaban (brand name

More information

DISORDERS OF VENOUS SYSTEM

DISORDERS OF VENOUS SYSTEM DISORDERS OF VENOUS SYSTEM Varicose Veins Any dilated, elongated and tortuous vein irrespective of size Varicose veins are common in the superficial veins of the leg which are subject to high pressure

More information